Breaks Categories: News

WednesdayOct 25, 2023 10:50 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Agreements for Private Placement, Preferred Investment Options

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, has entered into a definitive agreement for the issue and sale of more than 3 million common shares, or prefunded warrants in lieu thereof. Specifically, the company agreed to a private placement of 3,012,049 common shares priced at $0.83 per share. In addition, the company entered an agreement for an associated preferred investment option as well as a definitive agreement regarding specific outstanding preferred investment options issued in November 2022. The announcement outlines specifics of the agreement. The company also…

Continue Reading

TuesdayOct 24, 2023 12:24 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced its selection of a lead Alzheimer’s disease drug candidate, named INM-901, following positive results from several proof-of-concept studies in a validated Alzheimer’s treatment model. InMed will be advancing cannabinoid analog INM-901 in its pharmaceutical drug development program. “The most recent studies of INM-901 demonstrate promising disease-modifying effects in an Alzheimer’s disease treatment model,” said Dr. Eric Hsu, InMed’s SVP of preclinical research and development. “We are optimistic that the next stage of studies will continue to show how…

Continue Reading

WednesdayOct 18, 2023 9:57 am

CannabisNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Strengthen Position in Alternative Mental-Health Treatments Sector

Lucy Scientific Discovery (NASDAQ: LSDI), a pioneer in alternative mental-health treatments, is working to provide ingredients for effective mental-health treatment and therapies, including psilocybin and MDMA. According to a recent article spotlighting LSDI, the company is “well positioned” to support the mental-health space as it continues to grow. The article noted that mental-health issues are impacting millions of Americans a year and that treatments are finally evolving to treat these issues. Prescriptions for selective serotonin reuptake inhibitors (“SSRIs”) have long been a mainstay in the industry, but they don’t work for everyone and often have debilitating side effects. The article…

Continue Reading

FridayOct 13, 2023 12:18 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Inks Global Collaboration, License Agreement with SulfoSyn

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has granted a new global, exclusive license to SulfoSyn Limited; the license is for the exclusive global use of all nonpharmaceutical applications of Lexaria’s proprietary DehydraTECH-sulforaphane, including the right to authorize sublicenses. According to the announcement, Lexaria has already received an up-front cash payment, and the agreement outlines minimumongoing payments, royalties and manufacturing revenues. Nonpharmaceutical uses could include supplements, additives, foods, dietary ingredients and more. In addition to the license agreement, the two companies have a broader agreement that, for at least the next two years, Lexaria will conduct certain…

Continue Reading

ThursdayOct 12, 2023 1:03 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Portfolio Expansion to 37 Granted Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has been granted two new patents by the Canadian Intellectual Property Office (“CIPO”), increasing its portfolio to 37 granted patents. According to the update, Canadian Patent #2,984,917, “ Stable Ready-to-drink Beverage Compositions Comprising Lipophilic Active Agents, ” was granted on Sept. 26, 2023, and expires Dec. 1, 2036. The patent recognizes Lexaria’s innovations in delivering lipophilic (fat-based) active drugs and active molecules suspended in a water-based format. Lexaria’s DehydraTECH technology can be used in dry formats such as capsules and pills, as well as…

Continue Reading

WednesdayOct 04, 2023 2:50 pm

CannabisNewsBreaks – Santo Mining Corp. (SANP), Planta Vida S.A.S. Enter Strategic Joint Venture

Santo (OTC: SANP), a vertically integrated 4th industrial revolution firm specializing in end-to-end blockchain-as-a-service (“BaaS”) solutions and other cutting-edge technologies such as IoT, AI, NFTs, and data analytics, has announced its entry into a strategic joint venture agreement with Planta Vida S.A.S. According to the announcement, the company will outline the business operations of this agreement during the days and weeks to come. “This agreement gives us, for the first time, a true sold partnership with a group that is highly skilled and respected in the cannabis industry,” said Frank Yglesias, CEO of Santo. “This will allow us to focus…

Continue Reading

MondayOct 02, 2023 9:30 am

CannabisNewsBreaks — Boston Hemp Inc. Releases Status Update Indicating Participants of Nationwide Marijuana Affiliate Program Earn Up to $10K per Month

Boston Hemp, a trailblazing force in the legal cannabis industry, is reporting on the success of its THCa Flower Affiliate Program. The company says that affiliates who participate in the monthly subscription program are earning as much as $10,000 a month. According to the update, the success of these individuals is rooted in the evolution of the cannabis industry in the United States, which the company calls “remarkable” and observes that it is a driving force behind, with its game-changing program designed for individuals looking for a successful career in the growing legal marijuana sector. The THCa Flower Affiliate Program…

Continue Reading

FridaySep 29, 2023 4:06 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases FY 2023 Report, Shares Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, is reporting on the financial results for its fiscal year 2023, the period ending June 30, 2023. In addition, the company provided a status update on its pharmaceutical drug-development programs as well as the commercial segment for BayMedica LLC, its wholly owned subsidiary. Highlights of the report include total sales for subsidiary BayMedica of rare cannabinoids in the health and wellness sector reaching $4.1 million, an increase of 280% over the previous fiscal year and $2.3 million in revenue for…

Continue Reading

FridaySep 29, 2023 1:47 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on Upcoming $1.6M Registered Direct Offering

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has entered into a securities purchase agreement with a single healthcare-focused institutional investor; the agreement is for the purchase of 1,618,330 shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering. According to the announcement, Lexaria also agreed to issue and sell warrants to purchase up to 1,618,330 shares of common stock to the same investor. The combined effective offering price for each share of common stock (or pre-funded warrant in lieu thereof) and accompanying warrant is $0.97. The warrants will become exercisable six…

Continue Reading

ThursdaySep 28, 2023 1:53 pm

CannabisNewsBreaks — 420 Expo Releases Agenda, Announces Media Support for New Jersey’s Premier BYOC Cannabis Convention

420 Expo, New Jersey’s first-ever Bring Your Own Cannabis (“BYOC”) consumer convention, is partnering with CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the more than 60 brands at IBN (InvestorBrandNetwork). According to the announcement, CNW is returning as a media sponsor and official newswire for the expo, which is slated for Sept. 29–Oct. 1, 2023, in Edison, New Jersey. The largest BYOC consumer convention in the Northeast, 420 Expo offers cannabis connoisseurs, budding entrepreneurs and passionate enthusiasts the ideal venue to learn more about cannabis and CBD while also engaging with industry veterans and enjoying an…

Continue Reading